Informazioni sul prodotto
GAL-021 is an orally active compound that is being developed for the treatment of inflammatory diseases. GAL-021 is a small molecule that binds to the α subunit of acetylcholine esterase, which blocks the activity of this enzyme and reduces inflammation. GAL-021 has been shown to be effective in clinical studies for reducing inflammation associated with autoimmune diseases and depression. The drug also increased the numbers of regulatory T cells in mice with experimental asthma. GAL-021 has been shown to be safe and well tolerated in humans at doses up to 200 mg per day, with no significant side effects or adverse events reported.
Proprietà chimiche
Richiesta tecnica su: 3D-FFC34199 GAL-021
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
